Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ibtissem Hannachi

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Reproductive Sciences (Thousand Oaks, Calif.)|September 10, 2020
Increased Sperm DNA Fragmentation in Infertile Men with Varicocele: Relationship with Apoptosis, Seminal Oxidative Stress, and Spermatic ParametersOumaima Ammar, Oumayma Tekeya, Ibtissem Hannachi, et al.
La Tunisie Medicale|September 17, 2024
Distribution of CYP3A4 and CYP3A5 Polymorphisms and Genotype Combination Implicated in Tacrolimus MetabolismIbtissem Hannachi, Zohra Chadli, Emna Kerkeni, et al.
Toxicology and Applied Pharmacology|September 19, 2020
Dosing algorithm for Tacrolimus in Tunisian Kidney transplant patients: Effect of CYP 3A4*1B and CYP3A4*22 polymorphismsNadia Ben-Fredj, Ibtissem Hannachi, Zohra Chadli, et al.
Therapeutic Drug Monitoring|August 8, 2018
Distribution of Genetic Polymorphisms of Genes Implicated in Thiopurine Drugs MetabolismZohra Chadli, Emna Kerkeni, Ibtissem Hannachi, et al.
Transplant Immunology|July 26, 2023
A prospective validation of a population pharmacokinetic model of tacrolimus in Tunisian kidney transplant patientsNadia Ben-Fredj, Ibtissem Hannachi, Haifa Ben-Romdhane, et al.
Therapie|April 16, 2025
Usefulness of thiopurines therapeutic drug monitoring in patients with inflammatory bowel diseaseZohra Chadli, Ibtissem Hannachi, Nadia Ben Fredj, et al.
La Tunisie Medicale|October 23, 2024
Zohra Chadli, Kmar Kasraoui, Ibtissem Hannachi, et al.
The Pharmacogenomics Journal|August 27, 2020
Influence of CYP3A polymorphisms on tacrolimus pharmacokinetics in kidney transplant recipientsIbtissem Hannachi, Zohra Chadli, Emna Kerkeni, et al.
Toxicology and Applied Pharmacology|April 11, 2020
Effect of CYP3A4*22 and CYP3A4*1B but not CYP3A5*3 polymorphisms on tacrolimus pharmacokinetic model in Tunisian kidney transplantIbtissem Hannachi, Nadia Ben Fredj, Zohra Chadli, et al.
The Pharmacogenomics Journal|March 2, 2021
Development of a population pharmacokinetic model and Bayesian estimators for isoniazid in Tunisian tuberculosis patientsMohammed Alshaikheid, Nadia Ben Fredj, Ibtissem Hannachi, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Reproductive Sciences (Thousand Oaks, Calif.)|September 10, 2020
Increased Sperm DNA Fragmentation in Infertile Men with Varicocele: Relationship with Apoptosis, Seminal Oxidative Stress, and Spermatic ParametersOumaima Ammar, Oumayma Tekeya, Ibtissem Hannachi, et al.
La Tunisie Medicale|September 17, 2024
Distribution of CYP3A4 and CYP3A5 Polymorphisms and Genotype Combination Implicated in Tacrolimus MetabolismIbtissem Hannachi, Zohra Chadli, Emna Kerkeni, et al.
Toxicology and Applied Pharmacology|September 19, 2020
Dosing algorithm for Tacrolimus in Tunisian Kidney transplant patients: Effect of CYP 3A4*1B and CYP3A4*22 polymorphismsNadia Ben-Fredj, Ibtissem Hannachi, Zohra Chadli, et al.
Therapeutic Drug Monitoring|August 8, 2018
Distribution of Genetic Polymorphisms of Genes Implicated in Thiopurine Drugs MetabolismZohra Chadli, Emna Kerkeni, Ibtissem Hannachi, et al.
Transplant Immunology|July 26, 2023
A prospective validation of a population pharmacokinetic model of tacrolimus in Tunisian kidney transplant patientsNadia Ben-Fredj, Ibtissem Hannachi, Haifa Ben-Romdhane, et al.
Therapie|April 16, 2025
Usefulness of thiopurines therapeutic drug monitoring in patients with inflammatory bowel diseaseZohra Chadli, Ibtissem Hannachi, Nadia Ben Fredj, et al.
La Tunisie Medicale|October 23, 2024
Zohra Chadli, Kmar Kasraoui, Ibtissem Hannachi, et al.
The Pharmacogenomics Journal|August 27, 2020
Influence of CYP3A polymorphisms on tacrolimus pharmacokinetics in kidney transplant recipientsIbtissem Hannachi, Zohra Chadli, Emna Kerkeni, et al.
Toxicology and Applied Pharmacology|April 11, 2020
Effect of CYP3A4*22 and CYP3A4*1B but not CYP3A5*3 polymorphisms on tacrolimus pharmacokinetic model in Tunisian kidney transplantIbtissem Hannachi, Nadia Ben Fredj, Zohra Chadli, et al.
The Pharmacogenomics Journal|March 2, 2021
Development of a population pharmacokinetic model and Bayesian estimators for isoniazid in Tunisian tuberculosis patientsMohammed Alshaikheid, Nadia Ben Fredj, Ibtissem Hannachi, et al.
Pageof 2